Related Experiment Video

Updated: Jan 3, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.4K

Phototherapy in the Pediatric Population

Michelle C Juarez1, Anna L Grossberg2

  • 1The Johns Hopkins School of Medicine, 733 North Broadway, Baltimore, MD 21205, USA.

Dermatologic Clinics
|November 23, 2019
PubMed

Insights

Phototherapy is an effective treatment for pediatric skin conditions, especially for severe cases. Further research is needed to confirm long-term safety and efficacy in children.

Area of Science:

  • Pediatric Dermatology
  • Photomedicine

Background:

  • Phototherapy is a recognized treatment for various pediatric skin conditions.
  • It serves as a crucial option for children with severe dermatologic issues or those unresponsive to initial therapies.
  • Existing studies indicate the efficacy and safety of phototherapy in pediatric patients.

Purpose of the Study:

  • To review recent evidence on the efficacy and safety of phototherapy in children.
  • To focus on common photosensitive dermatoses in the pediatric population.
  • To highlight special considerations for phototherapy use in children.

Main Methods:

  • Literature review of recent studies on pediatric phototherapy.
  • Analysis of evidence for efficacy and safety.
  • Focus on common pediatric photosensitive skin conditions.

Main Results:

  • Phototherapy demonstrates efficacy and safety in treating pediatric skin conditions.
  • Evidence supports its use in severe or treatment-resistant cases.
  • Recent data reinforces its value in managing photosensitive dermatoses in children.

Conclusions:

  • Phototherapy is a viable and effective treatment for pediatric skin conditions.
  • Special considerations are necessary for its application in children.
  • More extensive controlled and long-term studies are warranted to further solidify its role.

Keywords:
Atopic dermatitisChildrenExcimerNBUVBNarrowbandPUVAPediatricPhototherapy

More Related Videos

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

12.3K
Minimal Erythema Dose MED Testing06:24

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

42.7K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
177
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
156
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
215
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
206
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
218